A 16-year-old girl presents with primary amenorrhea. On examination, she has normal breast development (Tanner stage 5), normal pubic hair, and a blind-ending vaginal pouch. Pelvic ultrasound shows absent uterus and fallopian tubes but normal ovaries. Which feature best distinguishes Müllerian agenesis from androgen insensitivity syndrome in this clinical context?

Explanation

## Distinguishing Müllerian Agenesis from Androgen Insensitivity Syndrome ### The Best Discriminating Feature **Key Point:** The single best feature that distinguishes Müllerian agenesis (MRKH syndrome) from complete androgen insensitivity syndrome (CAIS) is the **karyotype**: Müllerian agenesis has a normal female karyotype (46,XX), while CAIS has a male karyotype (46,XY). This is the fundamental biological distinction between the two conditions. ### Why Option A is Insufficient Option A — "Absence of uterus and upper two-thirds of vagina with normal secondary sexual characteristics" — describes anatomical findings that are **shared by both conditions**. Both MRKH and CAIS present with absent uterus, a blind-ending vaginal pouch, and normal breast development (Tanner 5). Therefore, this feature does **not** distinguish between the two. ### Comparison Table | Feature | Müllerian Agenesis (MRKH) | Androgen Insensitivity Syndrome (AIS) | |---------|---------------------------|----------------------------------------| | **Karyotype** | **46,XX** ✓ | **46,XY** | | **Gonads** | Normal ovaries | Testes (intra-abdominal) | | **Ovarian function** | Normal, functional | Absent (no ovaries) | | **Breast development** | Normal (Tanner 5) | Normal (Tanner 5) | | **Pubic/axillary hair** | Normal female pattern | Sparse or absent | | **Uterus** | Absent | Absent | | **Vagina** | Upper 2/3 absent, lower 1/3 present | Blind-ending pouch | | **Hormone levels** | Normal FSH/LH, normal estrogen | Elevated LH, normal/high testosterone | | **Primary pathology** | Müllerian duct agenesis | Androgen receptor insensitivity | ### Why Other Options Are Incorrect - **Option A:** Anatomical absence of uterus and upper vagina is seen in **both** conditions — not a distinguishing feature. - **Option C:** Functional ovaries are present in MRKH but absent in AIS (testes are present instead). While this is a valid distinction, it is a *consequence* of the karyotype difference, and the karyotype itself is the more fundamental and direct discriminator used clinically. - **Option D:** Elevated FSH/LH is not characteristic of either condition in the typical presentation; both may have variable hormone patterns and this is not a reliable discriminator. ### Clinical Pearl **Clinical Pearl:** In clinical practice, karyotyping is the definitive investigation to distinguish MRKH (46,XX) from CAIS (46,XY). The presence of normal ovaries on ultrasound supports MRKH, but karyotype remains the gold-standard distinguishing feature. In CAIS, the gonads are testes (often intra-abdominal), not ovaries, and AMH from these testes causes Müllerian regression. **High-Yield:** Per Padubidri & Daftary and standard gynecology texts, the **46,XX karyotype** is the hallmark of Müllerian agenesis and the best single feature distinguishing it from CAIS (46,XY). [cite:Padubidri & Daftary 3e Ch 12; Shaw's Textbook of Gynaecology]